Holly has practiced in the field of Intellectual Property since 2022, specialising in the life sciences sector.
Before entering the patent profession, Holly graduated from the University of Oxford with a Bachelor of Arts in Biological Sciences and a Master of Science in Immunology. Holly’s master’s project involved developing and assessing the immunogenicity of bivalent viral vector vaccines against Influenza and Respiratory syncytial virus. Following this Holly joined the Jenner Institute for Vaccine Research where she undertook clinical serology studies to investigate the humoral response induced by the Oxford/AstraZeneca COVID-19 vaccine.
Holly joined Secerna as a Trainee Patent Attorney in August 2022.
